Fuminori Teraishi

2.2k total citations
80 papers, 1.8k citations indexed

About

Fuminori Teraishi is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Fuminori Teraishi has authored 80 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 32 papers in Molecular Biology and 18 papers in Surgery. Recurrent topics in Fuminori Teraishi's work include Cell death mechanisms and regulation (14 papers), Virus-based gene therapy research (13 papers) and Cancer-related Molecular Pathways (11 papers). Fuminori Teraishi is often cited by papers focused on Cell death mechanisms and regulation (14 papers), Virus-based gene therapy research (13 papers) and Cancer-related Molecular Pathways (11 papers). Fuminori Teraishi collaborates with scholars based in Japan, United States and China. Fuminori Teraishi's co-authors include Jason J. Davis, Bingliang Fang, Lidong Zhang, Toshiyoshi Fujiwara, Shuhong Wu, Hongbo Zhu, Shunsuke Kagawa, Noriaki Tanaka, Wei Guo and Satoru Kyo and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Fuminori Teraishi

64 papers receiving 1.7k citations

Peers

Countries citing papers authored by Fuminori Teraishi

Since Specialization

Citations

This map shows the geographic impact of Fuminori Teraishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuminori Teraishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuminori Teraishi more than expected).

Fields of papers citing papers by Fuminori Teraishi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuminori Teraishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuminori Teraishi. The network helps show where Fuminori Teraishi may publish in the future.

Co-authorship network of co-authors of Fuminori Teraishi

This figure shows the co-authorship network connecting the top 25 collaborators of Fuminori Teraishi. A scholar is included among the top collaborators of Fuminori Teraishi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuminori Teraishi. Fuminori Teraishi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	D3 lymph node dissection in colon cancer patients aged 90 years and over: Is it justified? A multi‐institutional retrospective study 2025 ·Colorectal Disease ·Fuminori Teraishi, (unknown), Ryo Inada, Toshiharu Mitsuhashi, (unknown), (unknown), (unknown), (unknown), T Fujiwara, (unknown)	0
2	Clinical Impacts of Minimally Invasive Transperineal Abdominoperineal Resection in Crohn's Disease: A Retrospective Analysis 2025 ·Asian Journal of Endoscopic Surgery ·Yoshitaka Kondo, Nobuhiko Kanaya, (unknown), T. Inokuchi, Setsuro Hiraoka, Yusuke Yoshida, (unknown), Kunitoshi Shigeyasu, Fuminori Teraishi, (unknown), Toshiyoshi Fujiwara	0
3	Cancer-associated fibroblasts promote pro-tumor functions of neutrophils in pancreatic cancer via IL-8: potential suppression by pirfenidone 2025 ·Cancer Immunology Immunotherapy ·(unknown), Shunsuke Kagawa, (unknown), (unknown), M. Yoshimoto, (unknown), (unknown), (unknown), (unknown), Satoru Kikuchi, Yoshihiko Kakiuchi, Fuminori Teraishi, Kosei Takagi, Toshiaki Ohara, Hiroshi Tazawa, Toshiyoshi Fujiwara	4
4	BNCT pancreatic cancer treatment strategy with glucose-conjugated boron drug 2024 ·Biomaterials ·Takuya Fujimoto, Fuminori Teraishi, (unknown), Tomoyuki Tajima, Yoshinori Sakurai, Natsuko Kondo, (unknown), (unknown), (unknown), Mizuki Kitamatsu, Atsushi Fujimura, Minoru Suzuki, Yutaka Takaguchi, Kunitoshi Shigeyasu, Toshiyoshi Fujiwara, Hiroyuki Michiue	7
5	Subjective global assessment for nutritional screening and its impact on surgical outcomes: A prospective study in older patients with colorectal cancer 2024 ·Langenbeck s Archives of Surgery ·Fuminori Teraishi, Yusuke Yoshida, (unknown), Nobuhiko Kanaya, (unknown), Kunitoshi Shigeyasu, Yoshitaka Kondo, (unknown), (unknown), Y. Matsuoka, Hiroshi Morimatsu, Toshiharu Mitsuhashi, T Fujiwara	0
6	Primary ileal myeloid sarcoma presenting with bowel obstruction: a case report 2024 ·Surgical Case Reports ·(unknown), Nobuhiko Kanaya, Yoshitaka Kondo, Yoshihiko Kakiuchi, Shinji Kuroda, (unknown), Hajime Kashima, (unknown), Satoru Kikuchi, Kunitoshi Shigeyasu, Fuminori Teraishi, Shunsuke Kagawa, Toshiyoshi Fujiwara	1
7	ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer 2023 ·Scientific Reports ·(unknown), Kunitoshi Shigeyasu, Yuzo Umeda, Shuya Yano, Sho Takeda, Kazuhiro Yoshida, Tomokazu Fuji, Ryuichi Yoshida, (unknown), (unknown), Toshiaki Takahashi, Yoshitaka Kondo, Hiroyuki Kishimoto, Yoshiko Mori, Fuminori Teraishi, Hideki Yamamoto, Hiroyuki Michiue, Keiichiro Nakamura, Hiroshi Tazawa, Toshiyoshi Fujiwara	11
8	A Case Report of Non-typical Annular Pancreas Diagnosed during Laparoscopic Gastric Surgery. 2023 ·PubMed ·Toshiaki Takahashi, Yoshihiko Kakiuchi, (unknown), (unknown), Sho Takeda, Kunitoshi Shigeyasu, Yoshitaka Kondo, Fuminori Teraishi, (unknown), Toshiyoshi Fujiwara	1
9	Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma 2022 ·British Journal of Cancer ·(unknown), Yuzo Umeda, Kazuhiro Yoshida, Kunitoshi Shigeyasu, (unknown), (unknown), Sho Takeda, Ryuichi Yoshida, (unknown), Tomokazu Fuji, Kazuyuki Matsumoto, Hiroyuki Kishimoto, Hiroyuki Michiue, Fuminori Teraishi, Hironari Kato, Hiroshi Tazawa, Hiroyuki Yanai, (unknown), Ajay Goel, Toshiyoshi Fujiwara	19
10	Preoperative chemoradiotherapy versus surgery alone for advanced low rectal cancer: a large multicenter cohort study in Japan 2020 ·Surgery Today ·Tomonori Akagi, Masafumi Inomata, (unknown), Meiki Fukuda, Tsuyoshi Konishi, Shunsuke Tsukamoto, Fuminori Teraishi, Heita Ozawa, Keitaro Tanaka, Koya Hida, Yoshiharu Sakai, Masahiko Watanabe	5
11	Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer 2018 ·Cancer Letters ·Sho Takeda, Kunitoshi Shigeyasu, Yoshinaga Okugawa, Kazuhiro Yoshida, Yoshiko Mori, Shuya Yano, Kazuhiro Noma, Yuzo Umeda, Yoshitaka Kondo, Hiroyuki Kishimoto, Fuminori Teraishi, Takeshi Nagasaka, Hiroshi Tazawa, Shunsuke Kagawa, Toshiyoshi Fujiwara, Ajay Goel	48
12	A Case of Ileocecal Actinomycosis after Chemoradiation for Uterine Cervical Cancer 2013 ·The Japanese Journal of Gastroenterological Surgery ·Naoya Kawakita, Y. Fukui, (unknown), (unknown), Fuminori Teraishi, (unknown), Toshio Nakamura, Madoka Hamada, Yasuo Shima, Toshikatsu Taniki	0
13	A case of anaplastic carcinoma of the pancreas coexisting with IPMC 2010 ·Suizo ·Akihito Kozuki, Yasuo Shima, Fuminori Teraishi, Tadashi Horimi, Jun Iwata	4
14	Esophageal Intramural Pseudodiverticulosis With Esophageal Strictures Successfully Treated With Dilation Therapy 2006 ·The Annals of Thoracic Surgery ·Fuminori Teraishi, Toshiyoshi Fujiwara, (unknown), (unknown), (unknown), Katsuaki Sato, Noriaki Tanaka	10
15	Anticancer Activity of 5-Benzylidene-2-Phenylimino-1, 3-Thiazolidin-4-one (BPT) Analogs 2006 ·Medicinal Chemistry ·Shuhong Wu, Wei Guo, Fuminori Teraishi, (unknown), Kumaralal Kaluarachchi, Lei Zhang, Joseph Davis, Fengping Dong, Bing Yan, Bin Fang	34
16	Downregulation of XIAP and induction of apoptosis by the synthetic cyclin-dependent kinase inhibitor GW8510 in non-small cell lung cancer cells 2006 ·Cancer Biology & Therapy ·Fengqin Dong, Wei Guo, Lidong Zhang, Shuhong Wu, Fuminori Teraishi, Jason J. Davis, Bingliang Fang	20
17	Activation of c‐Jun NH₂‐terminal kinase is required for gemcitabine's cytotoxic effect in human lung cancer H1299 cells 2005 ·FEBS Letters ·Fuminori Teraishi, Lidong Zhang, Wei Guo, Fengqin Dong, Jason J. Davis, Anning Lin, Bingliang Fang	29
18	JNK1-dependent antimitotic activity of thiazolidin compounds in human non-small-cell lung and colon cancer cells 2005 ·Cellular and Molecular Life Sciences ·Fuminori Teraishi, Shuhong Wu, (unknown), (unknown), Jason J. Davis, Wei Guo, (unknown), B Fang	30
19	Induction of S-phase arrest and p21 overexpression by a small molecule 2[[3-(2,3-dichlorophenoxy)propyl] amino]ethanol in correlation with activation of ERK 2004 ·Oncogene ·Hongbo Zhu, Lidong Zhang, Shuhong Wu, Fuminori Teraishi, Jason J. Davis, Dietmar Jacob, Bingliang Fang	84
20	Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoter 2004 ·Cancer Gene Therapy ·Dietmar Jacob, Jason J. Davis, Lidong Zhang, Hongbo Zhu, Fuminori Teraishi, Bingliang Fang	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact